Skip to main content
Clinical Trials/ISRCTN12205188
ISRCTN12205188
Completed
未知

Prospective randomised controlled trial to investigate the effectiveness of inhalers for the relief of breathlessness in patients with lung cancer and chronic obstructive pulmonary disease (COPD)

The Royal Marsden NHS Foundation Trust (UK)0 sites72 target enrollmentFebruary 28, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
ung cancer, Chronic obstructive pulmonary disease (COPD)
Sponsor
The Royal Marsden NHS Foundation Trust (UK)
Enrollment
72
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2011
End Date
September 30, 2016
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Royal Marsden NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or female, age \> 35 years
  • 2\. Diagnosis of non\-small cell lung cancer (NSCLC), small cell lung cancer (SCLC) or mesothelioma
  • 3\. Diagnosis of COPD
  • 4\. Subjective dyspnoea of visual analogue score (VAS) \= 4

Exclusion Criteria

  • 1\. Involvement in any other studies of breathlessness
  • 2\. Reversible causes of breathlessness
  • 3\. Patients receiving radiotherapy, chemotherapy, biological therapy or surgery. Or a plan to commence these treatments within 4 weeks
  • 4\. Current use of bronchodilators either inhaled or oral (aminophyline, methyxanthines) except for short\-acting bronchodilators
  • 5\. Recent change to oral corticosteroid therapy dose (within 1 week of randomisation)
  • 6\. Current use of beta\-blockers for any reason
  • 7\. Current use of anti\-cholinergic containing drugs
  • 8\. Current use of potent CYP30 inhibitors (ritonavir, ketoconazole, itraconazole)
  • 9\. Patients with the following conditions:
  • 9\.1\. Asthma

Outcomes

Primary Outcomes

Not specified

Similar Trials